1. Home
  2. ROMA vs NXL Comparison

ROMA vs NXL Comparison

Compare ROMA & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROMA
  • NXL
  • Stock Information
  • Founded
  • ROMA 2018
  • NXL 2010
  • Country
  • ROMA Hong Kong
  • NXL United States
  • Employees
  • ROMA N/A
  • NXL N/A
  • Industry
  • ROMA Savings Institutions
  • NXL Medical Specialities
  • Sector
  • ROMA Finance
  • NXL Health Care
  • Exchange
  • ROMA Nasdaq
  • NXL Nasdaq
  • Market Cap
  • ROMA 8.4M
  • NXL 10.0M
  • IPO Year
  • ROMA 2024
  • NXL 2022
  • Fundamental
  • Price
  • ROMA $0.79
  • NXL $3.23
  • Analyst Decision
  • ROMA
  • NXL Hold
  • Analyst Count
  • ROMA 0
  • NXL 1
  • Target Price
  • ROMA N/A
  • NXL N/A
  • AVG Volume (30 Days)
  • ROMA 61.5K
  • NXL 533.6K
  • Earning Date
  • ROMA 12-31-2024
  • NXL 11-08-2024
  • Dividend Yield
  • ROMA N/A
  • NXL N/A
  • EPS Growth
  • ROMA N/A
  • NXL N/A
  • EPS
  • ROMA N/A
  • NXL N/A
  • Revenue
  • ROMA $1,265,509.00
  • NXL $162,078.00
  • Revenue This Year
  • ROMA N/A
  • NXL $56.86
  • Revenue Next Year
  • ROMA N/A
  • NXL $167.44
  • P/E Ratio
  • ROMA N/A
  • NXL N/A
  • Revenue Growth
  • ROMA N/A
  • NXL 26.00
  • 52 Week Low
  • ROMA $0.40
  • NXL $0.25
  • 52 Week High
  • ROMA $11.80
  • NXL $4.49
  • Technical
  • Relative Strength Index (RSI)
  • ROMA 47.29
  • NXL 42.43
  • Support Level
  • ROMA $0.76
  • NXL $3.25
  • Resistance Level
  • ROMA $0.87
  • NXL $4.49
  • Average True Range (ATR)
  • ROMA 0.09
  • NXL 0.35
  • MACD
  • ROMA 0.01
  • NXL -0.17
  • Stochastic Oscillator
  • ROMA 49.77
  • NXL 7.26

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage and overcome various business matters arising from such factors related to ESG, sustainability and climate change. it provides tailored-made sustainability solutions to meet the client's specific needs. Its mission is to provide its clients with a one-stop destination for high-quality and holistic sustainability and climate change-related consulting services to support a more sustainable, balanced and inclusive future for its clients' organizations and the world.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: